NCT00349518 2016-02-17Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALLBristol-Myers SquibbPhase 2/3 Withdrawn